Background: Obesity is an important pediatric public health problem associated with increased risk of many complications in childhood and increased morbidity and mortality throughout adult life. Objectives: To assess the prevalence of Metabolic Syndrome in obese children and the relationship between Metabolic Syndrome and Body mass index (BMI), sex, age and family risk factors like obesity, hypertension, diabetes mellitus and cardiovascular disease. Materials and Methods: An analytic cross-sectional study was conducted in 178 overweight and obese children and adolescents aged 5-16 years old seen at the General Pediatric Clinic of the Tishreen University Hospital between March 2020 and February 2021. Weight, high, waist Circumference and blood pressure were measured. Blood samples were taken after 12 hours fasting and fasting blood glucose (FBG), total cholesterol (T Cho), high- density lipoprotein cholesterol (HDL) and low- density lipoprotein cholesterol (LDL) were measured. The Metabolic Syndrome MS was diagnosed based on pediatric and adolescent criteria adapted from the National Cholesterol Education Program Third Adult Treatment Panel (NCEP-ATP III) definition. Results: A total of 178 children, 82 males (46.1%) and 96 females (53.9%) with mean age 9.9±2.5 SD were in our study. Out of the 178 children, 62 (34.8%) were overweight, 101 (56.7%) obese and 15 (8.4%) were severe obese. According to the NCEP ATP III, (32.6%) out of (178) children were diagnosed with MS. Among children with MS, most components of MS were increased waist circumference WC (93.1%), increased TG (86.2%), reduced HDL (51.7%), increased BP (50%) and increased FBS (25.9%). MS prevalence was 12.9%, 36.6%, 86.7% in overweight, obese and severe obese children respectively
Published in | American Journal of Pediatrics (Volume 7, Issue 3) |
DOI | 10.11648/j.ajp.20210703.14 |
Page(s) | 113-116 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Metabolic Syndrome, Obese, Overweight, Cardiovascular Disease
[1] | Vaquero Alvarez, M., Aparicio-Martinez, P., Fonseca Pozo, F. J., Valle Alonso, J., Blancas Sánchez, I. M., & Romero-Saldaña, M. (2020). A sustainable approach to the metabolic syndrome in children and its economic burden. International journal of environmental research and public health, 17 (6), 1891. |
[2] | Lee, K. (2008). The World Health Organization (WHO). Routledge. |
[3] | St Geme, J. W., Blum, N. J., Shah, S. S., Tasker, R. C., & Wilson, K. M. (2020). Nelson textbook of pediatrics. |
[4] | Klish, W. J., Kirkland, J., & Motil, K. (2015). Comorbidities and complications of obesity in children and adolescents. Up To Date [Internet].(Consultado noviembre 2009). Disponible en: http://www.uptodate.com/contents/comorbidities-and-complications-of-obesity-in-children-and-adolescents. |
[5] | Mantzoros, C. (2005). Insulin resistance: Definition and clinical spectrum. Up to Date Online, 14, 1-5. |
[6] | Mattoo, T. K. (2009). Definition and diagnosis of hypertension in children and adolescents. Up To Date. |
[7] | DeBoer, M. D. (2019). Assessing and managing the metabolic syndrome in children and adolescents. Nutrients, 11 (8), 1788. |
[8] | Özer, S., Kazanc, N. Ö., Sönmezgöz, E., Karaaslan, E., Altunta, B., & Kuyucu, Y. E. (2015). Higher HDL levels are a preventive factor for metabolic syndrome in obese Turkish children. Nutricion hospitalaria, 31 (1), 307-312. |
[9] | Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W.,... & Caprio, S. (2004). Obesity and the metabolic syndrome in children and adolescents. New England journal of medicine, 350 (23), 2362-2374. |
[10] | Sangun, Ö., Dündar, B., Köşker, M., Pirgon, Ö., & Dündar, N. (2011). Prevalence of metabolic syndrome in obese children and adolescents using three different criteria and evaluation of risk factors. Journal of clinical research in pediatric endocrinology, 3 (2), 70. |
[11] | Damiri, B., Alhala, A. A., Najjar, L., & Alqadome, S. (2018). Metabolic syndrome and its risk factors among overweight and obese Palestinian schoolchildren using IDF and NCEP-ATP/III definitions. Ann Clin Lab Res, 6 (3), 242. |
[12] | Shah, S. M., Aziz, F., Al Meskari, F., Al Kaabi, J., Khan, U. I., & Jaacks, L. M. (2020). Metabolic syndrome among children aged 6 to 11 years, Al Ain, United Arab Emirates: Role of obesity. Pediatric diabetes, 21 (5), 735-742. |
[13] | Medinaa, O. N., Arriagaa, R. V., Valverdeb, L. F., Lópeza, C. P. R., Skidmorec, O. M., Torresd, M. C. G.,... & Lópeza, S. G. (2015). Prevalence of metabolic syndrome in overweight and obese schoolchildren. |
[14] | Rodrigues, L. G., Mattos, A. P., & Koifman, S. (2011). Prevalence of metabolic syndrome in overweight and obese outpatient children and adolescents: comparative analysis using different clinical definitions. Revista Paulista de Pediatria, 29, 178-185. |
APA Style
Douaa Kharbotly, Ahmad Chreitah, Muhammed Imad Khayat. (2021). Metabolic Syndrome in Obese Children over Five Years Old. American Journal of Pediatrics, 7(3), 113-116. https://doi.org/10.11648/j.ajp.20210703.14
ACS Style
Douaa Kharbotly; Ahmad Chreitah; Muhammed Imad Khayat. Metabolic Syndrome in Obese Children over Five Years Old. Am. J. Pediatr. 2021, 7(3), 113-116. doi: 10.11648/j.ajp.20210703.14
AMA Style
Douaa Kharbotly, Ahmad Chreitah, Muhammed Imad Khayat. Metabolic Syndrome in Obese Children over Five Years Old. Am J Pediatr. 2021;7(3):113-116. doi: 10.11648/j.ajp.20210703.14
@article{10.11648/j.ajp.20210703.14, author = {Douaa Kharbotly and Ahmad Chreitah and Muhammed Imad Khayat}, title = {Metabolic Syndrome in Obese Children over Five Years Old}, journal = {American Journal of Pediatrics}, volume = {7}, number = {3}, pages = {113-116}, doi = {10.11648/j.ajp.20210703.14}, url = {https://doi.org/10.11648/j.ajp.20210703.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20210703.14}, abstract = {Background: Obesity is an important pediatric public health problem associated with increased risk of many complications in childhood and increased morbidity and mortality throughout adult life. Objectives: To assess the prevalence of Metabolic Syndrome in obese children and the relationship between Metabolic Syndrome and Body mass index (BMI), sex, age and family risk factors like obesity, hypertension, diabetes mellitus and cardiovascular disease. Materials and Methods: An analytic cross-sectional study was conducted in 178 overweight and obese children and adolescents aged 5-16 years old seen at the General Pediatric Clinic of the Tishreen University Hospital between March 2020 and February 2021. Weight, high, waist Circumference and blood pressure were measured. Blood samples were taken after 12 hours fasting and fasting blood glucose (FBG), total cholesterol (T Cho), high- density lipoprotein cholesterol (HDL) and low- density lipoprotein cholesterol (LDL) were measured. The Metabolic Syndrome MS was diagnosed based on pediatric and adolescent criteria adapted from the National Cholesterol Education Program Third Adult Treatment Panel (NCEP-ATP III) definition. Results: A total of 178 children, 82 males (46.1%) and 96 females (53.9%) with mean age 9.9±2.5 SD were in our study. Out of the 178 children, 62 (34.8%) were overweight, 101 (56.7%) obese and 15 (8.4%) were severe obese. According to the NCEP ATP III, (32.6%) out of (178) children were diagnosed with MS. Among children with MS, most components of MS were increased waist circumference WC (93.1%), increased TG (86.2%), reduced HDL (51.7%), increased BP (50%) and increased FBS (25.9%). MS prevalence was 12.9%, 36.6%, 86.7% in overweight, obese and severe obese children respectively}, year = {2021} }
TY - JOUR T1 - Metabolic Syndrome in Obese Children over Five Years Old AU - Douaa Kharbotly AU - Ahmad Chreitah AU - Muhammed Imad Khayat Y1 - 2021/07/09 PY - 2021 N1 - https://doi.org/10.11648/j.ajp.20210703.14 DO - 10.11648/j.ajp.20210703.14 T2 - American Journal of Pediatrics JF - American Journal of Pediatrics JO - American Journal of Pediatrics SP - 113 EP - 116 PB - Science Publishing Group SN - 2472-0909 UR - https://doi.org/10.11648/j.ajp.20210703.14 AB - Background: Obesity is an important pediatric public health problem associated with increased risk of many complications in childhood and increased morbidity and mortality throughout adult life. Objectives: To assess the prevalence of Metabolic Syndrome in obese children and the relationship between Metabolic Syndrome and Body mass index (BMI), sex, age and family risk factors like obesity, hypertension, diabetes mellitus and cardiovascular disease. Materials and Methods: An analytic cross-sectional study was conducted in 178 overweight and obese children and adolescents aged 5-16 years old seen at the General Pediatric Clinic of the Tishreen University Hospital between March 2020 and February 2021. Weight, high, waist Circumference and blood pressure were measured. Blood samples were taken after 12 hours fasting and fasting blood glucose (FBG), total cholesterol (T Cho), high- density lipoprotein cholesterol (HDL) and low- density lipoprotein cholesterol (LDL) were measured. The Metabolic Syndrome MS was diagnosed based on pediatric and adolescent criteria adapted from the National Cholesterol Education Program Third Adult Treatment Panel (NCEP-ATP III) definition. Results: A total of 178 children, 82 males (46.1%) and 96 females (53.9%) with mean age 9.9±2.5 SD were in our study. Out of the 178 children, 62 (34.8%) were overweight, 101 (56.7%) obese and 15 (8.4%) were severe obese. According to the NCEP ATP III, (32.6%) out of (178) children were diagnosed with MS. Among children with MS, most components of MS were increased waist circumference WC (93.1%), increased TG (86.2%), reduced HDL (51.7%), increased BP (50%) and increased FBS (25.9%). MS prevalence was 12.9%, 36.6%, 86.7% in overweight, obese and severe obese children respectively VL - 7 IS - 3 ER -